Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03802305
Other study ID # RC18_0268
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 1, 2019
Est. completion date June 17, 2022

Study information

Verified date June 2022
Source Nantes University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The irreversible acute pulpitis is the most common emergency at the hospital during dental consultation. Pulpitis are characterized by intense and spontaneous oro-facial pains. In case of mandibular molar, the emergency treatment consists in realizing a pulpotomy (eviction of cameral pulp) under locoregional anesthesia called inferior alveolar nerve block (IANB). The latter represents a real challenge, since inflammation may decrease its action. To mitigate this deficiency and the drawbacks of the IANB (onset and duration of the anesthesia, bites risk reported with IANB) other anesthesias are proposed. In particular the computerized intraosseous technique anesthesia of which the Quicksleeper™ system is a part. However, according to the observers, a mild to severe tachycardia have been reported. Very few valid clinical trials exists on the subject, most being realized with systems of intraosseous anesthesia other than Quicksleeper™. Therefore, the aim of this study is first to analyze the variations of the cardiovascular parameters into two groups of anesthesia: locoregional anesthesia and Quicksleeper ™ system; and then, to compare the efficiency, side effects, operating consequences of both techniques. This study should provide better data about potential risk with computerized intraosseous technique such has Quicksleeper ™ system in healthy or cardiovascular risk patient.


Description:

When the patient arrive in the dental care center, an initial assessment is made to get the diagnosis of irreversible pulpitis: 1. Anamnesis: acute and spontaneous oro-facial pain, pulsatile severe intensity, which could irradiate toward the ear and/or jaw, exacerbated by cold or hot. 2. Clinical exams: positive vitality tests (electric test and cold pressor test) 3. Further examination (radiography) The inclusion and exclusion criteria will be checked and the informed consent of the patient will be taken. The patient is then randomized in one of the group (experimental or control). He will fill a questionnaire (Corah's scale) for evaluating his state of anxiety during care. A monitoring of cardiac parameters is made during the care at defined moment. The patient evaluates his pain himself with the VAS (Visual Analog Score), before the intervention. The anesthesia is carried out by only one experimenter, with the Quickslepper™ handpiece but different specific needles. Each patient receive 1.8 mL of 4% articaine 1:100 000 on a period of 2 minutes.


Recruitment information / eligibility

Status Completed
Enrollment 72
Est. completion date June 17, 2022
Est. primary completion date June 17, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - real irreversible pulpitis of a mandibular molar in dental emergency consultation at the Nantes hospital - Healthy patient without medical history (ASA 1), without treatment for heart rate distress (anti arrhythmic, beta-blocking drug) - Major and covered by the social security - Informed consent Exclusion Criteria: - ASA > 1 - Pregnant and breastfeeding women - Minors - Adults under guardianships - Adults deprived of freedom - Impossibility to obtain for informed consent - Allergy to anesthetic components - Contraindication of vasoconstrictor - Angle closure glaucoma - Pheochromocytomas - Bisphosphonate IV - Irradiated patient (upper respiratory and gastrointestinal tract cancer) - Contraindication with Mono-amino oxidase inhibitors - Acute apical periodontitis - Pulpitis on wisdom teeth - Vital teeth with fixed prosthesis - Active periodontal disease - Local anatomic difficulty - No reference tooth for vitality dental test

Study Design


Related Conditions & MeSH terms


Intervention

Device:
computerized intraosseous technique (Quicksleeper™)
The anesthetic solution is administered with a specific equipment allowing the injection step by step: anesthesia of the interdental papilla, positioning of the needle and perforating of the interdental space, Injection of the solution. All of these steps are based on an adjustment of the different part of this equipment.
loco-regional anesthesia (IANB technique)
The anesthetic solution is delivered by a needle near to the inferior alveolar nerve before it enters the mandibular foramen.

Locations

Country Name City State
France Nantes Universitary Hospital Nantes Loire-Atlantique

Sponsors (1)

Lead Sponsor Collaborator
Nantes University Hospital

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary time required (in minutes) to re-obtain the baseline cardiovascular parameters like reported before injection: expected event. 3 successive values of heart rate similar to those registered before injection.
3 successive values of blood pressure (diastolic and systolic) similar to those registered before injection.
at day 0, from T0 minute to T14 minutes
Secondary Compare the pain of the patient between the two anesthetic techniques Scores measured with Visual Analog Score( Heft-Parker's pain assessment) (minimum score : no pain ; maximal score : maximum pain unimaginable) 3 days
Secondary Compare the possible postoperative course between the 2 anesthetic techniques The postoperative course will be evaluated using a post-operative table to be completed by the patient at Day + 1, Day + 2 and Day + 3. Collection of information by phone call to the patient. The presence or absence of the following item is measured : pain after waking up, swelling, hematoma, seepage, higher tooth sensation, bite, possibility of feeding, mouth opening limitation. 3 days
See also
  Status Clinical Trial Phase
Withdrawn NCT03502135 - Efficacy of Tetracaine/Oxymetazoline Nasal Spray for Endodontic Treatment Phase 4
Completed NCT02437708 - Regenerative Endodontic Procedure of Immature Permanent Teeth With L-PRF: a Pilot Controlled, Clinical Trial Phase 3
Completed NCT03635515 - Occurrence of Post-op Pain Following Gentlewave N/A
Completed NCT04211519 - Analysis of Bacterial Microbiome of Endodontically Infected Primary and Permanent Teeth N/A
Completed NCT06176378 - A Clinical and Radiographic Evaluation of Low-Level Diode Laser Full Pulpotomy in Vital Permanent Teeth N/A
Completed NCT03551587 - Comparison Between the Vibringe and the Conventional Needle N/A
Recruiting NCT03883295 - Evaluation of Clinical and Radiological Success of Vital Amputation Treatment N/A
Completed NCT04700995 - Postoperative Pain After Using NiTi Instruments N/A
Completed NCT03472456 - Endodontic Medications for Irreversible Pulpitis: Articaine or Eugenol?
Active, not recruiting NCT04399135 - Accuracy of Pulp Sensibility Test on Teeth With Deep Periodontal Pocket N/A
Recruiting NCT04628845 - Endo-perio Lesion's Treatment With Using Diode Laser 940nm N/A
Completed NCT04228913 - Effect of Different Obturation Techniques on Postoperative Pain Phase 4